![]() |
인쇄하기
취소
|
It is observed that Green Cross is moving in the right direction to develop anticancer drugs.
Green Cross announced on the 3rd that the Ministry of Food and Drug Safety approved the plan for Phase 1 Clinical Study of ‘GC1118’, an Epidemic Growth Factor Receptor (EGFR) targeted therapy. The achievement is Green Cross’s another stepping stone for development of anticancer drugs, followed after t...